Patent · US Active

Recombinant herpes simplex virus useful for treating neoplastic disease

US7744899B2 · kind B2 · utility

9Cited by

8References

28Claims

0Family size

Assignees

THE UNIVERSITY OF CHICAGO · US
THE UAB RESEARCH FOUNDATION · US

Inventors

Richard J. Whitley · Birmingham, US
Bernard Roizman · Chicago, US

Key dates

Filing date	Oct 11, 2006
Grant date	Jun 29, 2010
Priority date	—
Expiry date	Apr 12, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/16643
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Recombinant herpes simplex viruses comprising DNA encoding cytokines and methods for treating neoplastic diseases using the inventive recombinant viruses are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.